Literature DB >> 35146359

Neglected and (re-)emergent infections of the CNS i n low-/middle-income countries.

Graciela Cárdenas1, Perla Salgado2, Enrique Laura-Foronda1, Ignacio Popoca-Rodriguez1, Rosa Delia Delgado-Hernández2, Rafael Rojas3, Enrique Palacios4.   

Abstract

Low- and middle-income countries (LMIC) have suffered from long-term health system deficiencies, worsened by poor living conditions, lack of sanitation, a restricted access to health facilities and running water, overcrowding, and overpopulation. These factors favor human displacement and deepen marginalization; consequently, their population endures a high burden of infectious diseases. In this context, the current epidemiological landscape and its impact on health and economic development are not promissory, despite the commitment by the international community to eradicate neglected tropical infections - especially tuberculosis and malaria, by 2030. Neglected and (re)-emerging infectious diseases affecting the central nervous system (CNS) are a major public health concern in these countries, as they cause a great morbidity and mortality; furthermore, survivors often suffer from severe neurological disabilities. Herein, we present a retrospective review focused on some neglected and (re)-emerging infectious diseases, including neurocysticercosis, malaria, rabies, West Nile virus encephalitis, tuberculosis, neuroborreliosis, and SARS-CoV-2 in LMIC. A retrospective review of studies on selected neglected and (re)-emerging infectious diseases in LMIC was performed, including reports by the World Health Organization (WHO) published within the last five years. Data on infection by SARS-CoV-2 were provided by the John Hopkins University Coronavirus Resource Center. CNS neglected and (re)-emerging infectious diseases remain as important causes of disease in LMIC. An alarming increase in the prevalence of malaria, tuberculosis, and cysticercosis is observed in the region, compounded by the recent COVID-19 pandemic. The WHO is currently supporting programs/efforts to cope with these diseases. Herein, we highlight the epidemiological burden of some CNS infections in LMIC, and their clinical and neuroimaging features, to facilitate an accurate diagnosis, considering that most of these diseases will not be eradicated in the short term; instead, their incidence will likely increase along with poverty, inequality, and related socioeconomic problems.
Copyright © 2016 - 2021 InfezMed.

Entities:  

Keywords:  Neglected; central nervous system; emergent; infections; low/middle income countries

Year:  2021        PMID: 35146359      PMCID: PMC8805465          DOI: 10.53854/liim-2904-3

Source DB:  PubMed          Journal:  Infez Med        ISSN: 1124-9390


  46 in total

Review 1.  New Insights into Malaria Pathogenesis.

Authors:  Christopher A Moxon; Matthew P Gibbins; Dagmara McGuinness; Danny A Milner; Matthias Marti
Journal:  Annu Rev Pathol       Date:  2019-10-24       Impact factor: 23.472

Review 2.  Cerebral malaria.

Authors:  Ange Landela Luzolo; Dieudonné Mumba Ngoyi
Journal:  Brain Res Bull       Date:  2019-01-15       Impact factor: 4.077

Review 3.  Human rabies: neuropathogenesis, diagnosis, and management.

Authors:  Thiravat Hemachudha; Gabriella Ugolini; Supaporn Wacharapluesadee; Witaya Sungkarat; Shanop Shuangshoti; Jiraporn Laothamatas
Journal:  Lancet Neurol       Date:  2013-05       Impact factor: 44.182

4.  Brain Imaging of Patients with COVID-19: Findings at an Academic Institution during the Height of the Outbreak in New York City.

Authors:  E Lin; J E Lantos; S B Strauss; C D Phillips; T R Campion; B B Navi; N S Parikh; A E Merkler; S Mir; C Zhang; H Kamel; M Cusick; P Goyal; A Gupta
Journal:  AJNR Am J Neuroradiol       Date:  2020-08-20       Impact factor: 3.825

Review 5.  Psychosis in Borrelia burgdorferi infection - part I: epidemiology, pathogenesis, diagnosis and treatment of neuroborreliosis.

Authors:  Szymon Brodziński; Tadeusz Nasierowski
Journal:  Psychiatr Pol       Date:  2019-06-30       Impact factor: 1.657

6.  Estimating the global burden of endemic canine rabies.

Authors:  Katie Hampson; Laurent Coudeville; Tiziana Lembo; Maganga Sambo; Alexia Kieffer; Michaël Attlan; Jacques Barrat; Jesse D Blanton; Deborah J Briggs; Sarah Cleaveland; Peter Costa; Conrad M Freuling; Elly Hiby; Lea Knopf; Fernando Leanes; François-Xavier Meslin; Artem Metlin; Mary Elizabeth Miranda; Thomas Müller; Louis H Nel; Sergio Recuenco; Charles E Rupprecht; Carolin Schumacher; Louise Taylor; Marco Antonio Natal Vigilato; Jakob Zinsstag; Jonathan Dushoff
Journal:  PLoS Negl Trop Dis       Date:  2015-04-16

7.  Magnetic Resonance Imaging of Cerebral Malaria Patients Reveals Distinct Pathogenetic Processes in Different Parts of the Brain.

Authors:  Sanjib Mohanty; Laura A Benjamin; Megharay Majhi; Premanand Panda; Sam Kampondeni; Praveen K Sahu; Akshaya Mohanty; Kishore C Mahanta; Rajyabardhan Pattnaik; Rashmi R Mohanty; Sonia Joshi; Anita Mohanty; Ian W Turnbull; Arjen M Dondorp; Terrie E Taylor; Samuel C Wassmer
Journal:  mSphere       Date:  2017-06-07       Impact factor: 4.389

Review 8.  Is SARS-CoV-2 Also an Enteric Pathogen With Potential Fecal-Oral Transmission? A COVID-19 Virological and Clinical Review.

Authors:  Siyuan Ding; T Jake Liang
Journal:  Gastroenterology       Date:  2020-04-27       Impact factor: 22.682

9.  Brain MRI Findings in Severe COVID-19: A Retrospective Observational Study.

Authors:  Stéphane Kremer; François Lersy; Jérome de Sèze; Jean-Christophe Ferré; Adel Maamar; Béatrice Carsin-Nicol; Olivier Collange; Fabrice Bonneville; Gilles Adam; Guillaume Martin-Blondel; Marie Rafiq; Thomas Geeraerts; Louis Delamarre; Sylvie Grand; Alexandre Krainik
Journal:  Radiology       Date:  2020-06-16       Impact factor: 11.105

10.  SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.

Authors:  Markus Hoffmann; Hannah Kleine-Weber; Simon Schroeder; Nadine Krüger; Tanja Herrler; Sandra Erichsen; Tobias S Schiergens; Georg Herrler; Nai-Huei Wu; Andreas Nitsche; Marcel A Müller; Christian Drosten; Stefan Pöhlmann
Journal:  Cell       Date:  2020-03-05       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.